title: Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
authors.forename: Josef
authors.initials: J
authors.lastname: Finsterer
authors.forename: Marlies
authors.initials: M
authors.lastname: Frank
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Krexner
mesh_terms: D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine